C
AMLX icon

Covestor’s Amylyx Pharmaceuticals AMLX Stock Holding History

Covestor’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
+9
New +$127 ﹤0.01% 2217
2024
Q3 		– Sell
-43
Closed – – 2166
2024
Q2 		$0 Sell
43
-31
-42% -$60 ﹤0.01% 2200
2024
Q1 		$0 Sell
74
-3,652
-98% -$47.8K ﹤0.01% 2196
2023
Q4 		$55K Buy
3,726
+3,722
+93,050% +$57K 0.04% 804
2023
Q3 		$0 Hold
4
– – ﹤0.01% 2069
2023
Q2 		$0 Hold
4
– – ﹤0.01% 2089
2023
Q1 		$0 Hold
4
– – ﹤0.01% 1969
2022
Q4 		$0 Sell
4
-1
-20% -$35 ﹤0.01% 2015
2022
Q3 		$0 Buy
+5
New +$125 ﹤0.01% 1933

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Covestor's AMLX Position: Q1 2026 in Review

Covestor opened a new position in Amylyx Pharmaceuticals (AMLX) in Q1 2026: 9 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2217 among its holdings. This is a return to the name: Covestor previously reported a position in AMLX as recently as Q2 2024.

Covestor first reported a position in AMLX in Q3 2022 and has held it in 9 quarters since. The position peaked at $55K in Q4 2023. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Covestor held 9 shares of Amylyx Pharmaceuticals worth $0 as of Q1 2026.
  • Amylyx Pharmaceuticals was a new Covestor position in Q1 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2217 holding.
  • Covestor first reported a position in Amylyx Pharmaceuticals in Q3 2022 and has held it in 9 quarters since.
  • Covestor's Amylyx Pharmaceuticals position peaked at $55K in Q4 2023.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.